Ginkgo Bioworks
(NYSE) DNA
Ginkgo Bioworks Financials at a Glance
Market Cap
$319.80M
Revenue (TTM)
$170.16M
Net Income (TTM)
$312.76M
EPS (TTM)
$-5.68
P/E Ratio
-0.96
Dividend
$0.00
Beta (Volatility)
2.46 (High)
Dividend
$0.00
Beta (Volatility)
2.46 (High)
Price
$5.94
Volume
11,993
Open
$5.71
Price
$5.94
Volume
11,993
Open
$5.71
Previous Close
$5.48
Daily Range
$5.71 - $6.07
52-Week Range
$5.00 - $17.58
Dividend
$0.00
Beta (Volatility)
2.46 (High)
Price
$5.94
Volume
11,993
Open
$5.71
Previous Close
$5.48
Daily Range
$5.71 - $6.07
52-Week Range
$5.00 - $17.58
DNA News
DNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ginkgo Bioworks
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
485
CEO
Jason Kelly, PhD
Website
www.ginkgo.bioHeadquarters
Boston, MA 02210, US
DNA Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-51%
Return on Capital
-31%
Return on Assets
-28%
Earnings Yield
-1.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$319.80M
Shares Outstanding
58.36M
Volume
11.99K
Short Interest
0.00%
Avg. Volume
1.15M
Financials (TTM)
Gross Profit
$138.63M
Operating Income
$315.28M
EBITDA
$254.61M
Operating Cash Flow
$171.06M
Capital Expenditure
$7.67M
Free Cash Flow
$178.72M
Cash & ST Invst.
$422.62M
Total Debt
$417.08M
Ginkgo Bioworks Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$33.40M
-23.8%
Gross Profit
$41.55M
+21.4%
Gross Margin
1.24%
N/A
Market Cap
$319.80M
N/A
Market Cap/Employee
$383.46K
N/A
Employees
834
N/A
Net Income
$80.75M
+24.9%
EBITDA
$34.87M
+75.7%
Quarterly Fundamentals
Net Cash
$5.54M
-94.1%
Accounts Receivable
$24.03M
+7.1%
Inventory
$0.00
N/A
Long Term Debt
$417.08M
-4.9%
Short Term Debt
$0.00
-100.0%
Return on Assets
-27.93%
N/A
Return on Invested Capital
-30.80%
N/A
Free Cash Flow
$63.00M
-12.2%
Operating Cash Flow
$47.68M
-12.4%